Results 41 to 50 of about 51,402 (230)

Análise dos Laudos de exames histopatológicos de alopécia em pacientes do Hospital Universitário Polydoro Ernani de São Thiago entre o ano de 2000 e 2005. [PDF]

, 2006
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Vegini, Julyan Baum
core  

Polarized microscopy as a helpful tool to distinguish chronic nonscarring alopecia from scarring alopecia

, 2012
Nonscarring alopecia differs from scarring alopecia on pathologic examination by the preservation of follicular units and lack of follicular dropout. However, long-standing cases of active nonscarring hair loss can show follicular dropout on pathologic ...
Miteva, Mariya, Tosti, Antonella
core   +1 more source

Comorbidities of Primary Scarring Alopecias: A Retrospective Multi‐Site Cross‐Sectional Study

JEADV Clinical Practice
Background To date, limited research has compared the systemic comorbidities of primary scarring alopecia types. Such research may provide insight into shared disease mechanisms, elucidate novel pathways for therapeutics, and identify those most at risk ...
Arielle Carolina Mora Hurtado, Sarah Gonzalez, Nicole C. Syder, Arthur Manasyan, Tiana Thompson, Lucy Harvey, Jack Rodman, Nada Elbuluk   +7 more
doaj   +1 more source

The diagnosis and management of alopecia

South African Family Practice, 2012
Alopecia refers to loss of hair from the scalp or other hair-bearing areas of the body. Alopecia has a significant impact on quality of life. It is commonly associated with loss of self-esteem and emotional stress. It can be non-scarring (noncicatricial)
M.H. Motswaledi, K. Mathekga
doaj   +1 more source

Alopecia Areata in a Patient Receiving Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma

JEADV Clinical Practice, EarlyView.
ABSTRACT Alopecia areata (AA) is an autoimmune disease characterized by non‐scarring hair loss of the scalp and/or body, with an unpredictable and variable clinical course. Its etiology is not entirely understood, although evidence suggests that environmental, immunological, and genetic factors contribute to disease development.
Marco Rubatto, Eleonora Bongiovanni, Veronica Arese, Michela Camilla Milanesio, Alessia Reali, Massimo Chiarpenello, Gianmauro Numico, Marcella Occelli   +7 more
wiley   +1 more source

Study of AhR expression in scarring alopecia

, 2019
The evidence for AhR overexpression in unaffected or "normal-appearing" scalp of lichen planopilaris and frontal fibrosing alopecia suggests an environmental role for dioxins in the pathomechanism of these scarring disorders and therefore, news models ...
Doche, Isabella
core   +1 more source

Alopecia universalis during treatment with leflunomide and adalimumab - Case report [PDF]

Anais Brasileiros de Dermatologia, 2014
Alopecia areata is a non-scarring form of alopecia that can be localized or widespread. Its etiology is unknown, but immunological factors are implicated in its pathogenesis.
Rosana Lazzarini, Gabriela Cunha Capareli, Roberta Buense, Rute Facchini Lellis   +3 more
doaj   +1 more source

Nail Disorders in Systemic Conditions

JEADV Clinical Practice, EarlyView.
ABSTRACT Nail findings in children can be indicative of an underlying systemic disease. Many of these findings are seen in multiple entities and are not specific to one disease. The importance of specifically examining for these nail changes cannot be overstated.
Jane Sanders Bellet
wiley   +1 more source

Early-Onset Graham-Little-Piccardi-Lasseur Syndrome with Cutaneous Lichen Planus – A Rare Case Report and Review of Literature

Clinical Dermatology Review
Graham-Little-Piccardi-Lasseur syndrome (GLPLS) is a rare condition characterized by lichen planopilaris with scarring alopecia of the scalp and nonscarring alopecia of the axilla, groin, and pubis with keratosis pilaris.
Saritha Mohanan, R Remya Raj, K V Bharathi, P Suba   +3 more
doaj   +1 more source

Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review

JEADV Clinical Practice, EarlyView.
This systematic review identifies consistent clinical patterns of alopecia areata associated with IL‐17 and IL‐23 inhibitors, most frequently involving secukinumab and ustekinumab. Disease severity varied widely, and management often required biologic discontinuation or therapeutic switching.
Isabella Kamholtz, Simonetta I. Gaumond, Joaquin J. Jimenez   +2 more
wiley   +1 more source